The expression of three inhibitory receptors, BDCA2, leukocyte-associated immunoglobulin-like receptor 1 (LAIR-1), and ILT3, on human pDC is reduced in SLE patients compared to HC [94, 106, 107]. Here, LILRB4 is linked to systemic lupus erythematosus.